Historical Controls?

Por Gaynon, Paul S.
Publicado no Haematologica (2017)

Remission is good - relapse is bad

Por Gaynon, Paul S.
Publicado no Haematologica (2018)

Treating refractory leukemias in childhood, role of clofarabine

Por Harned, Theresa M, Gaynon, Paul S
Publicado em 2008

End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia

Por Parekh, Chintan, Gaynon, Paul S., Abdel-Azim, Hisham
Publicado no Pediatr Blood Cancer (2015)

Improving Access To Novel Agents For Childhood Leukemia

Por Sun, Weili, Gaynon, Paul S., Sposto, Richard, Wayne, Alan S.
Publicado no Cancer (2015)

Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL): Overview and Introduction to the Proceedings of the 2016 TACL Investigator Meeting

Por Wayne, Alan S., Shin-Kashiyama, Erika, Sposto, Richard, Gaynon, Paul
Publicado no Pediatr Hematol Oncol (2017)

Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Por Orgel, Etan, Sposto, Richard, Malvar, Jemily, Seibel, Nita L., Ladas, Elena, Gaynon, Paul S., Freyer, David R.
Publicado em 2014

High-Resolution Melting Curve Analysis, a Rapid and Affordable Method for Mutation Analysis in Childhood Acute Myeloid Leukemia

Por Liu, Yin, Tang, Jingyan, Wakamatsu, Peter, Xue, Huiliang, Chen, Jing, Gaynon, Paul S., Shen, Shuhong, Sun, Weili
Publicado em 2014

Constitutive Function of the Ikaros Transcription Factor in Primary Leukemia Cells from Pediatric Newly Diagnosed High-Risk and Relapsed B-precursor ALL Patients

Por Uckun, Fatih M., Ma, Hong, Ishkhanian, Rita, Arellano, Martha, Shahidzadeh, Anoush, Termuhlen, Amanda, Gaynon, Paul S., Qazi, Sanjive
Publicado em 2013

Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9)/l) with T cell Acute Lymphoblast...

Por Hastings, Caroline, Gaynon, Paul S., Nachman, James B., Sather, Hrland N., Lu, Xiaomin, Devidas, Meenakshi, Seibel, Nita L.
Publicado no Br J Haematol (2014)

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group

Por Freyer, David R., Devidas, Meenakshi, La, Mei, Carroll, William L., Gaynon, Paul S., Hunger, Stephen P., Seibel, Nita L.
Publicado em 2011

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and...

Por Stock, Wendy, La, Mei, Sanford, Ben, Bloomfield, Clara D., Vardiman, James W., Gaynon, Paul, Larson, Richard A., Nachman, James
Publicado em 2008

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

Por Sun, Weili, Liu, Huaying, Kim, Young, Karras, Nicole, Pawlowska, Anna, Toomey, Debbie, Kyono, Wade, Gaynon, Paul, Rosenthal, Joseph, Stein, Anthony
Publicado no J Hematol Oncol (2018)

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

Por Hunger, Stephen P., Lu, Xiaomin, Devidas, Meenakshi, Camitta, Bruce M., Gaynon, Paul S., Winick, Naomi J., Reaman, Gregory H., Carroll, William L.
Publicado em 2012

Long Term Results of the Children’s Cancer Group Studies for Childhood Acute Lymphoblastic Leukemia 1983–2002: a Children’s Oncology Group Report

Por Gaynon, Paul S., Angiolillo, Anne L., Carroll, William L., Nachman, James B., Trigg, Michael E., Sather, Harland N., Hunger, Stephen P., Devidas, Meenakshi
Publicado em 2009

Alternate-Week versus Continuous Dexamethasone Scheduling on the Risk of Osteonecrosis in Acute Lymphoblastic Leukemia: Results from the CCG-1961 Randomized Cohort Trial

Por Mattano, Leonard A, Devidas, Meenakshi, Nachman, James B, Sather, Harland N, Hunger, Stephen P, Steinherz, Peter G., Gaynon, Paul S, Seibel, Nita L
Publicado em 2012

Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia

Por Uckun, Fatih M., Qazi, Sanjive, Cely, Ingrid, Sahin, Kazim, Shahidzadeh, Anoush, Ozercan, Ibrahim, Yin, Qian, Gaynon, Paul, Termuhlen, Amanda, Cheng, Jianjun, Yiv, Seang
Publicado em 2013

Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Por Raetz, Elizabeth A., Borowitz, Michael J., Devidas, Meenakshi, Linda, Stephen B., Hunger, Stephen P., Winick, Naomi J., Camitta, Bruce M., Gaynon, Paul S., Carroll, William L.
Publicado em 2008

CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells

Por Myers, Dorothea E., Yiv, Seang, Qazi, Sanjive, Ma, Hong, Cely, Ingrid, Shahidzadeh, Anoush, Arellano, Martha, Finestone, Erin, Gaynon, Paul, Termuhlen, Amanda, Cheng, Jianjun, Uckun, Fatih
Publicado em 2014

Factors Influencing Survival After Relapse From Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Por Nguyen, Kim, Devidas, Meenakshi, Cheng, Su-Chun, La, Mei, Raetz, Elizabeth A., Carroll, William L., Winick, Naomi J., Hunger, Stephen P., Gaynon, Paul S., Loh, Mignon L.
Publicado em 2008